• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

[podcast]AstraZeneca’s Arun Krishna says Tagrisso-based combo promises new option in lung...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 26, 2023 at 10:42: AM
via Jack O’Brien interviews AstraZeneca’s Arun Krishna about a Tagrisso-based combo that promises a new option in lung cancer. Plus, updates on the new NIH director and the latest TikTok trend.

article source
 




Top Bottom
Back
Quote